Researchers in the December issue of Diabetes Care, found that the use of oral steroids can be a precipitating factor in some cases of new-onset diabetes
Read More »Diabetes In Control
More Support for Coffee’s Anti-diabetes Benefits
Drinking four or more cups of coffee a day could cut the risk of developing type-2 diabetes by over 23 per cent, say American and Finnish researchers.
Read More »Diabetes Vaccine Trial Offers New Hope
Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.
Read More »Rosiglitazone Delays Treatment Failure in Patients with Type 2 Diabetes
Initial treatment with rosiglitazone slowed the progression to monotherapy failure more effectively than either metformin or glyburide.
Read More »Twice Daily 70/30 Insulin + Metformin Vs. Lantus + Glimepiride in Type 2’s
Which treatment therapy was more effective?
Read More »‘Double Diabetes’ a New Threat: 1 Plus 2 Equals 3
The obesity epidemic is leading more people to develop type 1 and type 2 disease.
Read More »New York City Bans Trans Fat
Department of Health of NY City, shows Trans Fats the Door, after voting unanimously to ban the substance from the city’s restaurants.
Read More »Protein Beverage Reduces Hyperglycemia in Type 2 Diabetes
Drinking a protein hydrolysate/leucine beverage with meals reduces the prevalence of hyperglycemia in patients with type 2 diabetes, according to a new report.
Read More »After Gestational Diabetes, Postpartum Glucose Goes Unchecked
Only 45% women in the cohort underwent postpartum glucose testing, as recommended.
Read More »Diet Drug Acomplia (Rimonabant) Lowers Blood Sugars and Reduces Weight
New study results show patients with an HbA1c level of at least 8.5 when they started taking Acomplia saw their their blood sugar level decrease 1.9 points compared to 0.7 points in patients on a placebo.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.